Kinfe G Bishu1, Mulugeta Gebregziabher2,3, Clara E Dismuke2,1, Leonard E Egede4,5. 1. Center for Health Disparities Research, Division of General Internal Medicine, Medical University of South Carolina, 135 Rutledge Avenue, MSC 593, Charleston, SC, 29425-0593, USA. 2. Health Equity and Rural Outreach Innovation Center, Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, USA. 3. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA. 4. Health Equity and Rural Outreach Innovation Center, Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, USA. egedel@musc.edu. 5. Center for Health Disparities Research, Division of General Internal Medicine, Medical University of South Carolina, 135 Rutledge Avenue, MSC 593, Charleston, SC, 29425-0593, USA. egedel@musc.edu.
Abstract
OBJECTIVE: Although the national cost of missed workdays associated with diabetes has been estimated previously, we use the most recent available national data and methodology to update the individual and national estimates for the U.S population. METHODS: We identified 14,429 employed individuals ≥ 18 years of age in 2011 Medical Expenditure Panel Survey (MEPS) data. Diabetes and missed workdays were based on self-report, and cost was based on multiplying the daily wage rate for each individual by the number of missed days. Adjusted total national burden of missed workdays associated with diabetes was calculated using a novel two-part model to simultaneously estimate the association of diabetes with the number and cost of missed workdays. RESULTS: The unadjusted annual mean 2011 cost of missed workdays was $277 (95 % CI 177.0-378.0) for individuals with diabetes relative to $160 (95 % CI $130-$189) for those without. The incremental cost of missed workdays associated with diabetes was $120 (95 % CI $30.7-$209.1). Based on the US population in 2011, the unadjusted national burden of missed workdays associated with diabetes was estimated to be $2.7 billion, while the fully adjusted incremental national burden was estimated to be $1.1 billion. CONCLUSIONS: We provide more precise estimates of the cost burden of diabetes due to missed workdays on the U.S population. The high incremental and total cost burden of missed workdays among Americans with diabetes suggests the need for interventions to improve diabetes care management among employed individuals.
OBJECTIVE: Although the national cost of missed workdays associated with diabetes has been estimated previously, we use the most recent available national data and methodology to update the individual and national estimates for the U.S population. METHODS: We identified 14,429 employed individuals ≥ 18 years of age in 2011 Medical Expenditure Panel Survey (MEPS) data. Diabetes and missed workdays were based on self-report, and cost was based on multiplying the daily wage rate for each individual by the number of missed days. Adjusted total national burden of missed workdays associated with diabetes was calculated using a novel two-part model to simultaneously estimate the association of diabetes with the number and cost of missed workdays. RESULTS: The unadjusted annual mean 2011 cost of missed workdays was $277 (95 % CI 177.0-378.0) for individuals with diabetes relative to $160 (95 % CI $130-$189) for those without. The incremental cost of missed workdays associated with diabetes was $120 (95 % CI $30.7-$209.1). Based on the US population in 2011, the unadjusted national burden of missed workdays associated with diabetes was estimated to be $2.7 billion, while the fully adjusted incremental national burden was estimated to be $1.1 billion. CONCLUSIONS: We provide more precise estimates of the cost burden of diabetes due to missed workdays on the U.S population. The high incremental and total cost burden of missed workdays among Americans with diabetes suggests the need for interventions to improve diabetes care management among employed individuals.
Authors: Jennifer A Campbell; Alice Yan; Renee E Walker; Lance Weinhardt; Yang Wang; Rebekah J Walker; Leonard E Egede Journal: Sci Diabetes Self Manag Care Date: 2021-02-28
Authors: Emminarie Luisiana Lucas Garcia; David Debensason; Loïc Capron; Antoine Flahault; Jeanine Pommier Journal: BMC Public Health Date: 2018-04-16 Impact factor: 3.295
Authors: Jinshuo Li; Steve Parrott; Michael Sweeting; Andrew Farmer; Jamie Ross; Charlotte Dack; Kingshuk Pal; Lucy Yardley; Maria Barnard; Mohammed Hudda; Ghadah Alkhaldi; Elizabeth Murray Journal: J Med Internet Res Date: 2018-06-08 Impact factor: 5.428